Namida Lab Partners with Parkhill The Clinic for Women for BreastCancer Clinical Trials

FAYETTEVILLE, Ark. (October 1, 2021) – Parkhill The Clinic for Women has partnered with Namida Lab®to be a recruitment site for clinical trials around Melody®, the recently developed tear-based breast cancer screening test. Namida Lab is currently conducting studies to explore the utility of Melody® in the breast health continuum of care. Of specific interest is the application of Melody®for women with dense breast tissue, a particular area of concern in imaging. The study is fully funded by Namida Lab.

Dr.’s Robert Hix and Paige Partridge, OB/GYNs at Parkhill, will be recruiting patients for the study starting in October, coinciding with breast cancer awareness month. Dr. Partridge says, “We are excited to partner with Namida Lab to work toward increasing breast cancer screening options for women. Giving women and doctors another piece of information regarding breast health will help to improve care and allow women the opportunity to be more proactive around breast health”. Melody®is an additional breast cancer screening option for women to facilitate discussion between patients and their provider and is currently not intended to replace mammogram screening.

Parkhill The Clinic for Women, founded in 1965, provides total health care for women with a goal to provide innovative care for all ages. Parkhill doctors strive to be on the cutting edge of obstetrics and gynecology to continually serve the community with excellence.

If you are a patient at Parkhill and are interested in participating, please talk to your provider. If you are interested in being a part of future trials or studies with Namida Lab, please visit namidalab.com/contact us to enter your name and email address. 

 About Melody®  

Melody®is a lab-developed breast cancer screening test designed by women for women. As an innovative tear-based screening test, Melody® may lead to earlier cancer detection by increasing screening compliance, decreasing healthcare costs, and improving access to care. The test is a product of Namida Lab, Inc., headquartered in Fayetteville, Arkansas. Learn more at melody.care 

About Namida Lab  

Founded in 2019, Namida Lab Inc. is an Arkansas-based clinical stage biotech company specializing in biomarker-based testing, operating a high complexity Clinical Laboratory Improvement Amendments(CLIA)certified lab. Its Research & Development Lab works in tandem with the CLIA Lab to develop medical screening and diagnostic tools.